Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

NCT02178306 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan low dose
DRUG: Telmisartan high dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim